Can a 20-minute website ease psychosis distress in students?
NCT ID NCT06608498
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a single-session website called SPARK Coping in 50 college students at risk for psychosis. The goal was to see if it reduces distress, stigma, and improves attitudes toward treatment. Participants completed surveys at the start and two weeks later, with some getting the website right away and others after a delay.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- SPARK Coping (self-guided website)
- What this could lead to
- If it works, this could provide a low-cost, accessible way to help college students manage early psychosis symptoms and feel more comfortable seeking treatment.
- What could go wrong
- This was a small, early-stage study with only 50 participants and no long-term follow-up. The intervention is brief and may not be effective for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Jan 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 30 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Symptoms indicating risk for psychosis (a distress score \>= 20 on the Prodromal Questionnaire, Brief \[PQ-B\], per Savill et al., 2018; Early Intervention in Psychiatry and a positive frequency average score \>= 1.47 on the Community Assessment of Psychic Experiences (CAPE-P15), per Jaya et al., 2021 and Bukenaite et al., 2017) * Residence in the United States * Currently enrolled in a post-secondary college program at the University of Washington. Exclusion Criteria: * Inconsistent or implausible reporting of symptoms at screening as determined by empirically-determined methods for detecting malingering or inconsistency * Failure to demonstrate understanding of study details in comprehension screening
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prodromal symptoms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Washington
Seattle, Washington, 98195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists build a computer model of the brain to explain hearing voices
- Can schools catch teen mental health struggles before they escalate?
- Can a phone app curb cannabis use in early psychosis?
- Can a nasal insulin spray rev up brain energy and sharpen thinking in psychosis?
- Can virtual reality from home sharpen social skills in schizophrenia?
- Brain zaps in fast forward: a new hope for psychosis prevention?